Blood Lead and Other Metal Biomarkers as Risk Factors for Cardiovascular Disease Mortality.
Ontology highlight
ABSTRACT: Analyses of the Third National Health and Nutrition Examination Survey (NHANES III) in 1988 to 1994 found an association of increasing blood lead levels < 10 μg/dL with a higher risk of cardiovascular disease (CVD) mortality. The potential need to correct blood lead for hematocrit/hemoglobin and adjust for biomarkers for other metals, for example, cadmium and iron, had not been addressed in the previous NHANES III-based studies on blood lead-CVD mortality association. We analyzed 1999 to 2010 NHANES data for 18,602 participants who had a blood lead measurement, were ≥ 40 years of age at the baseline examination and were followed for mortality through 2011. We calculated the relative risk for CVD mortality as a function of hemoglobin- or hematocrit-corrected log-transformed blood lead throu
SUBMITTER: Aoki Y
PROVIDER: S-EPMC4706249 | biostudies-literature | 2016 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA